Rubella

Rubella and Congenital Rubella Syndrome

Generalities
Agent	Rubella virus, genus Rubullovirus, family Togaviridae
Incubation period	14-17 days (range 14-21 days)
Period of transmissibility	- 7 days before rash and 4 days after rash onset - From congenital rubella: infants shed the virus for several months after birth
Reservoir	Humans
Modes of transmission	- Person-to-person: direct contact with droplets - Infants with Congenital Rubella Syndrome shed large quantities of virus in their pharyngeal secretions and urine. - Materno-foetal transmission: 90% of infants born to women infected with rubella during the 1st trimester. The risk of transmission is 10-20% by the 16th week, and rare after the 20th week.
Clinical presentation	- Febril maculo-papular rash - Complications: thrombocytopenia (1/3000), post-infectious encephalitis (1/6000), rarely chronic arthritis - Congenital Rubella Syndrome: Congenital malformation as deafness, cataracts, microphtalmia, congenital glaucoma, pigmentary retinopathy, nystagmus, microcephaly, meningo-encephalitis, mental retardation, patent ductus arteious, atrial or ventricular septal defects, other congenital heart disease, purpura, hepatosplenomegaly, jaundice, radiolucent bone disease
Resources
Case definitions	- MOPH circular no 12 (2013): Acquired Rubella - MOPH circular no 45 (2007): Congenital Rubella Syndrome
Forms	- Rash reporting form - CRS reporting form - Rash investigation form - CRS investigation form
Data	- Rubella 2021 - Rubella 2020 - Rubella 2019 - Rubella 2018 - Rubella 2017 - Rubella 2016 - Rubella 2015

...

190

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
M01AB15	ALGIKEY	G	Ketorolac trometamine - 30mg/ml	30mg/ml	Injectable solution	873,498 L.L
N01BB02	LIDOCAINE ARWAN	G	Lidocaine (HCl) - 0.5%	0.5%	Injectable solution	1,995,158 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 2mcg/ml	2mcg/ml	Injectable solution	2,218,684 L.L
B02BX01	DICYNONE	B	Etamsylate - 250mg/2ml	250mg	Injectable solution	482,439 L.L
B05CX01	SOLUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	221,792 L.L
J01MA02	CIPROFLOXACINE PANPHARMA	G	Ciprofloxacin - 200mg/100ml	200mg/100ml	Injectable solution	4,914,432 L.L
M01AB15	KETO-AVI	G	Ketorolac tromethamine - 30mg/ml	30mg/ml	Injectable solution	106,164 L.L
N01BB02	LIDOCAINE ARWAN	G	Lidocaine (HCl) - 1%	1%	Injectable solution	1,995,158 L.L
A11CC03	ONE-ALPHA	B	Alfacalcidol - 2mcg/ml	2mcg/ml	Injectable solution	4,219,665 L.L
B05CX01	SOLUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	185,018 L.L
J01MA02	CIPROLON 200	G	Ciprofloxacin (lactate) - 200mg/100ml	200mg/100ml	Injectable solution	686,704 L.L
M01AB15	KETOLAC	G	Ketorolac trometamine - 30mg/2ml	30mg/2ml	Injectable solution	268,769 L.L
N01BB02	LIDOCAINE ARWAN	G	Lidocaine (HCl) - 1%	1%	Injectable solution	1,995,158 L.L
B05CX01	7.5% DEXTROSE INJECTION USP	G	Dextrose monohydrate - 7.5%	7.5g/100ml	Injectable solution	202,256 L.L
J01MA02	CIPROX	G	Ciprofloxacine (lactate) - 200mg/100ml	0.2%w/v	Injectable solution	520,067 L.L
N01BB02	? 1% LIDOCAINE HCL USP	G	Lidocaine HCl - 1%	1%	Injectable solution	76,791 L.L
B05CX01	DEXTROSE 7.5% INJECTION USP	G	Glucose - 7.5%	7.5%	Injectable solution	148,566 L.L
J01MA02	ESTECINA 200MG	G	Ciprofloxacine (lactate) - 200mg/100ml	200mg/100ml	Injectable solution	32,190,251 L.L
N01BB02	CHLORHYDRATE DE LIDOCAINE RENAUDIN	G	Lidocaine (HCl) - 10mg/ml	1%	Injectable solution	591,291 L.L
B05CX01	DEXTROSE 7.5% INJECTION USP	G	Glucose - 7.5%	7.5%	Injectable solution	179,456 L.L
J01MA02	LADININ	G	Ciprofloxacine (lactate) - 200mg/100ml	200mg/100ml	Injectable solution	892,591 L.L
N01BB02	LIDOCAINE HYDROCHLORIDE 1%	G	Lidocaine HCl - 1%	10mg/ml	Injectable solution	5,912,907 L.L
B05CX01	DEXTROSE 7.5% INJECTION USP	G	Glucose - 7.5%	7.5%	Injectable solution	163,184 L.L
J01MA02	VONECIP	G	Ciprofloxacin - 200mg/100ml	200mg/100ml	Injectable solution	579,196 L.L
J07AP03	TYPHIM VI	B	Salmonella typhi polysaccharides - 0.025mg/0.5ml	0.025mg/0.5ml	Injectable solution	1,118,077 L.L
N01BB02	LIDOCAINE- ORBUCELL	G	Lidocaine HCl - 1%	1%	Injectable solution	1,787,950 L.L
B05CX01	GLUCOSE INJ.	G	Glucose - 10g/20ml	50%	Injectable solution	5,038,066 L.L
J01MA02	CEFLOXINE	G	Ciprofloxacin - 400mg/200ml	400mg/200ml	Injectable solution	1,134,203 L.L
N01BB02	LIDOCAINE- ORBUCELL	G	Lidocaine HCl - 2%	2%	Injectable solution	1,787,950 L.L
N05CD08	MIDAZOLAM HAMELN	G	Midazolam (HCl) - 5mg/5ml	5mg/5ml	Injectable solution	529,474 L.L

...

190